Jade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications. Jade is headquartered in Waltham, MA.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 08/01/24 | $80,000,000 | Venture |
Braidwell Deep Track Capital Driehaus Capital Management Fairmount Funds Management  Franklin Templeton RTW Investments Venrock Healthcare Partners | undisclosed |
